Bayhealth announces the establishment of the first Hematology and Medical Oncology Fellowship program in Delaware.
This groundbreaking initiative aims to educate new fellows and equip them with …
Join our family of readers for as little as $5 per month and support local, unbiased journalism.
Already a member? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |
Bayhealth has established the first Hematology and Medical Oncology Fellowship program in Delaware.
This initiative aims to educate new fellows and equip them with the skills to deliver specialized care.
A fellow is defined as a physician who has completed both medical school and residency, and is board-eligible. Fellows choose to pursue additional training in a subspecialty of medicine — known as a fellowship. Fellowship programs give these individuals the in-depth training to become experts in that field.
The Hematology and Medical Oncology Fellowship will offer two positions a year. Interviews will be conducted from August through October, with the selections announced Nov. 29.
Over the course of the three-year program, fellows will gain experience in inpatient and outpatient settings, enabling them to develop a comprehensive understanding of the field. In addition, they will receive training in pathology, transfusion medicine and clinical research.
Fellows will also undergo a monthlong instruction in bone marrow transplants at Penn Medicine, Philadelphia. As a member of the Penn Cancer Network, Bayhealth is the only cancer program in Delaware affiliated with a National Cancer Institute–designated Comprehensive Cancer Center.
Leading the program is Bayhealth hematologist/oncologist Dr. Iftekhar Khan, who brings a wealth of expertise, ensuring the highest level of training and mentorship.
Applications are open and will be coordinated through the Electronic Residency Application Service. Visit bayhealthgme.org to learn more.